Compare ORGO & NATH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ORGO | NATH |
|---|---|---|
| Founded | 1985 | 1916 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Restaurants |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 348.6M | 412.2M |
| IPO Year | 2016 | 1996 |
| Metric | ORGO | NATH |
|---|---|---|
| Price | $2.27 | $100.81 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $8.50 | N/A |
| AVG Volume (30 Days) | ★ 1.0M | 16.1K |
| Earning Date | 05-07-2026 | 02-05-2026 |
| Dividend Yield | N/A | ★ 1.98% |
| EPS Growth | ★ 1600.00 | 22.29 |
| EPS | 0.15 | ★ 4.17 |
| Revenue | ★ $564,169,000.00 | $104,201,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $26.27 | N/A |
| P/E Ratio | ★ $14.94 | $24.18 |
| Revenue Growth | ★ 17.04 | 7.81 |
| 52 Week Low | $2.21 | $88.67 |
| 52 Week High | $7.08 | $118.32 |
| Indicator | ORGO | NATH |
|---|---|---|
| Relative Strength Index (RSI) | 29.84 | 55.64 |
| Support Level | N/A | $100.25 |
| Resistance Level | $2.51 | $102.05 |
| Average True Range (ATR) | 0.13 | 0.30 |
| MACD | 0.03 | -0.02 |
| Stochastic Oscillator | 22.62 | 68.18 |
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.
Nathan's Famous Inc is an owner of fast food franchises in the United States. The company's reportable segment includes the Branded Product Program, Product licensing, Restaurant operations and Corporate. Branded Product Program derives revenue principally from the sale of hot dog products either directly to foodservice operators or to various foodservice distributors who resell the products to foodservice operators. It generates maximum revenue from the Branded Product Program segment. Geographically, it derives a majority of revenue from the United States.